| Zugriffe | |
|---|---|
| 90-yttrium-ibritumomab tiuxetan as first-line treatment for follicular lymphoma: updated efficacy and safety results at an extended median follow-up of 9.6 years | 135 |
| März 2025 | April 2025 | Mai 2025 | Juni 2025 | Juli 2025 | August 2025 | September 2025 | |
|---|---|---|---|---|---|---|---|
| 90-yttrium-ibritumomab tiuxetan as first-line treatment for follicular lymphoma: updated efficacy and safety results at an extended median follow-up of 9.6 years | 6 | 2 | 13 | 10 | 5 | 25 | 2 |
| Zugriffe | |
|---|---|
| 2022_Rieger_etal.pdf | 34 |
